BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19700143)

  • 1. The transmembrane transport of metformin by osteoblasts from rat mandible.
    Ma L; Wu X; Ling-Ling E; Wang DS; Liu HC
    Arch Oral Biol; 2009 Oct; 54(10):951-62. PubMed ID: 19700143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapancreatic roles of glimepiride on osteoblasts from rat manibular bone in vitro: Regulation of cytodifferentiation through PI3-kinases/Akt signalling pathway.
    Ma P; Xiong W; Liu H; Ma J; Gu B; Wu X
    Arch Oral Biol; 2011 Apr; 56(4):307-16. PubMed ID: 21055727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture.
    Cortizo AM; Sedlinsky C; McCarthy AD; Blanco A; Schurman L
    Eur J Pharmacol; 2006 Apr; 536(1-2):38-46. PubMed ID: 16564524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cysteines in rat organic cation transporters rOCT1 (C322, C451) and rOCT2 (C451) critical for transport activity and substrate affinity.
    Sturm A; Gorboulev V; Gorbunov D; Keller T; Volk C; Schmitt BM; Schlachtbauer P; Ciarimboli G; Koepsell H
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F767-79. PubMed ID: 17567940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choline transport via choline transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT.
    Lee NY; Choi HM; Kang YS
    Placenta; 2009 Apr; 30(4):368-74. PubMed ID: 19246089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and functional reconstitution of the rat organic cation transporter OCT1.
    Keller T; Elfeber M; Gorboulev V; Reiländer H; Koepsell H
    Biochemistry; 2005 Sep; 44(36):12253-63. PubMed ID: 16142924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
    Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y
    J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between cimetidine, nitrofurantoin, and probenecid active transport into rat milk.
    Gerk PM; Oo CY; Paxton EW; Moscow JA; McNamara PJ
    J Pharmacol Exp Ther; 2001 Jan; 296(1):175-80. PubMed ID: 11123378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
    Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region.
    Gorboulev V; Shatskaya N; Volk C; Koepsell H
    Mol Pharmacol; 2005 May; 67(5):1612-9. PubMed ID: 15662045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes.
    Grover B; Buckley D; Buckley AR; Cacini W
    J Pharmacol Exp Ther; 2004 Mar; 308(3):949-56. PubMed ID: 14718608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
    Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
    Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
    Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
    Xenobiotica; 2007 Jun; 37(6):618-34. PubMed ID: 17614008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
    Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes.
    Inazu M; Takeda H; Matsumiya T
    J Neurochem; 2005 Sep; 94(5):1427-37. PubMed ID: 16000150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying saturable intestinal absorption of metformin.
    Proctor WR; Bourdet DL; Thakker DR
    Drug Metab Dispos; 2008 Aug; 36(8):1650-8. PubMed ID: 18458049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin-like growth factor I on the development of osteoblasts in hyperglycemia.
    Fang Y; Wang ZY; Mao Y; Xin HT; Ren GL; Bai XF
    Diabetes Res Clin Pract; 2006 Jul; 73(1):95-7. PubMed ID: 16413942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver uptake of biguanides in rats.
    Sogame Y; Kitamura A; Yabuki M; Komuro S
    Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin.
    Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS
    Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of manganese ions on cellular behavior of human osteoblasts in vitro.
    Lüthen F; Bulnheim U; Müller PD; Rychly J; Jesswein H; Nebe JG
    Biomol Eng; 2007 Nov; 24(5):531-6. PubMed ID: 17884722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.